WuXi PharmaTech Cayman: 52-Week High Recently Eclipsed (WX)
Shares of WuXi PharmaTech Cayman (NYSE:WX) traded today at $39.00, breaking its 52-week high. So far today approximately 183,000 shares have been exchanged, as compared to an average 30-day volume of 730,000 shares.
WuXi PharmaTech Cayman (NYSE:WX) is currently priced 2.6% above its average consensus analyst price target of $37.90. The stock should find initial support at its 50-day moving average (MA) of $35.80 and further support at its 200-day MA of $27.75.
WuXi PharmaTech Cayman Inc. provides pharmaceutical and biotechnology research and development outsourcing. The Company's services include discovery chemistry, service biology, analytical, pharmaceutical development, and manufacturing.
Over the past year, WuXi PharmaTech Cayman has traded in a range of $15.73 to $39.00 and is now at $38.90, 147% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.7% while the 200-day MA has risen 1.0%.
SmarTrend is tracking the current trend status for WuXi PharmaTech Cayman and will alert subscribers who have WX in their portfolio or watchlist when shares have changed trend direction.
Keywords: 52 week high/lows wuxi pharmatech cayman